A detailed history of Monarch Partners Asset Management LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 72,064 shares of RGNX stock, worth $581,556. This represents 0.5% of its overall portfolio holdings.

Number of Shares
72,064
Previous 99,520 27.59%
Holding current value
$581,556
Previous $2.63 Million 37.87%
% of portfolio
0.5%
Previous 0.79%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

SELL
$20.4 - $24.73 $560,102 - $678,986
-27,456 Reduced 27.59%
72,064 $1.63 Million
Q3 2022

Oct 31, 2022

BUY
$22.29 - $35.04 $2.22 Million - $3.49 Million
99,520 New
99,520 $2.63 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $349M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.